Io Biotech (IOBT)

IOBT

0.97

High/Low: 0.98 / 0.955 Chg/Chg%: -0.01 / -1.01% Volume: 11294
Technical Analysis Historical Data Financials News & Analysis

IOBT NEWS

IO Biotech (IOBT) Expected to Announce Quarterly Earnings on Tuesday By MarketBeat - 3 days ago

IO Biotech (NASDAQ:IOBT – Get Free Report) is expected to announce its Q1 2025 earnings results before the market opens on Tuesday, May 13th. Analysts expect the company to announce earnings of ($0.4… [+1588 chars]...

Read more
XTX Topco Ltd Makes New $26,000 Investment in IO Biotech, Inc. (NASDAQ:IOBT) By MarketBeat - 1 week ago

XTX Topco Ltd bought a new stake in shares of IO Biotech, Inc. (NASDAQ:IOBT – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & … [+2575 chars]...

Read more
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025 By IO - 2 weeks ago

NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, toda… [+4593 chars]...

Read more
IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170 By IO - 2 weeks ago

Preclinical data further support the potential of dual-antigen and TGF--directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity NEW YORK, April 25, 2025 (GLOBE NEWSWIRE… [+5056 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		207.68 2.96
1.45%
CVX 		141.11 -0.56
-0.4%
CAT 		350.67 1
0.29%
INTC 		21.56 0.04
0.16%
MSFT 		455.35 3.24
0.72%
DIS 		111.68 -1.26
-1.12%
DOW 		29.74 -0.43
-1.43%
CSCO 		64.67 3.38
5.51%
GS 		616.35 4.75
0.78%